Krantz David A, Hallahan Terrence W, Macri V James, Macri James N
Research Division, NTD Laboratories, Huntington Station, New York 11746, USA.
Prenat Diagn. 2005 Aug;25(8):635-40. doi: 10.1002/pd.1188.
OBJECTIVE(S): To estimate weight and ethnic group correction factors for first-trimester screening markers.
Ethnic-specific median MoM free beta hCG and pregnancy associated plasma protein A (PAPP-A) and delta nuchal translucency values were calculated for cohorts of maternal weight (20 lb each) using data from 51,206 patients undergoing first-trimester screening. False-positive rates for Down syndrome and trisomy 18 were evaluated both prior to and after weight and ethnicity adjustment.
Free beta hCG and PAPP-A significantly decreased with increasing maternal weight while nuchal translucency increased by a clinically insignificant amount. For free beta hCG the regression formula indicated that after accounting for maternal weight MoM values were 16% higher for African Americans, 6% higher for Asians and 9% lower for Hispanics compared to Caucasians (p < 0.001, p = 0.001, p < 0.001, respectively) but there was no significant difference for Asian Indians. For PAPP-A, MoM values were 35% higher for African Americans (p < 0.001) but were not significantly different for the other ethnic groups compared to Caucasians. Down syndrome false-positive rates did not vary with maternal weight prior to (p = 0.291) or after weight adjustment of biochemistry (p = 0.054). Trisomy 18 false-positive rates varied significantly with weight both before (OR = 1.455 per 20-pound increase, p < 0.001) and after (OR = 1.066 per 20-pound increase, p = 0.01) weight adjustment of biochemistry; however, the odds ratio was greatly reduced after weight adjustment.
CONCLUSION(S): The first-trimester screening markers, free beta hCG, PAPP-A and nuchal translucency vary with maternal weight and ethnicity. Adjustment of free beta hCG and PAPP-A is indicated but adjustment of nuchal translucency results may not be necessary.
估算孕早期筛查标志物的体重及种族校正因子。
利用51206例接受孕早期筛查患者的数据,针对不同体重队列(每20磅一组)计算特定种族的游离β-人绒毛膜促性腺激素(β-hCG)中位数倍数(MoM)、妊娠相关血浆蛋白A(PAPP-A)以及颈部透明带厚度差值(delta)。在进行体重和种族调整前后,分别评估唐氏综合征和18三体综合征的假阳性率。
随着孕妇体重增加,游离β-hCG和PAPP-A显著降低,而颈部透明带厚度虽有增加,但临床意义不大。对于游离β-hCG,回归公式表明,在考虑孕妇体重后,非裔美国人的MoM值比高加索人高16%,亚洲人高6%,西班牙裔低9%(p值分别<0.001、=0.001、<0.001),但印度裔亚洲人无显著差异。对于PAPP-A,非裔美国人的MoM值比高加索人高35%(p<0.001),但其他种族与高加索人相比无显著差异。在生化指标进行体重调整前(p=0.291)及调整后(p=0.054),唐氏综合征假阳性率均不随孕妇体重变化。18三体综合征假阳性率在生化指标体重调整前(每增加20磅,优势比=1.455,p<0.001)及调整后(每增加20磅,优势比=1.066,p=0.01)均随体重显著变化;然而,体重调整后优势比大幅降低。
孕早期筛查标志物游离β-hCG、PAPP-A和颈部透明带厚度随孕妇体重和种族而变化。游离β-hCG和PAPP-A需要进行调整,但颈部透明带厚度结果可能无需调整。